Re-Vana Announces Two New Team Appointments 

by | Jan 13, 2023 | News | 0 comments

RE-Vana Therapeutics CEO Michael J. O’Rourke announces two new team appointments:

Following our successful $11.9M Series A in November 2022, Re-Vana Therapeutics is delighted to further strengthen our team with two new appointments as we develop our sustained release biologics platforms:

Patrick Ruane is appointed Chief Operating Officer

Raj Thakur will join on a 2 year sabbatical from Queens University Belfast as Chief Technology Officer

Congrats to both Patrick and Raj

New Re-Vana career opportunities in Program Management, Quality Control, Biologics Development and Technical Services will be announced over the coming weeks.